Schedule 13G ownership disclosure
OnKure Therapeutics, Inc.
Class A Common Stock, par value $0.0001 per share · CUSIP: 68277Q105
Event date: 2025-05-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Cormorant Asset Management, LP
Shares: 0.00 · Class: 0%
- Bihua Chen
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-002418
- Form type
- SCHEDULE 13G/A
- Filer
- Cormorant Asset Management, LP
- CIK
- CIK 1583977
- Filed
- May 19, 2025
- Reporting period
- May 15, 2025
- Description
- Schedule 13G beneficial ownership